News
 Home > News > Archives > 2008 > Index
2008 News
INNOVATE-PCI enrolls first patient
Improved heart failure treatments don't improve long-term outcomes for patients
Combination therapy lowers cardiovascular risks for patients with high blood pressure
Patients with bleeding problems after heart attack less likely to have anti-blood clot therapy
Duke researchers propose operational improvements to modern clinical epidemiology
VADs are linked to high hospital costs, high death rates for Medicare patient
Rob Califf, ASCEND-HF trial highlighted in New York Times
Certain antidepressants don't increase risk of death for patients with heart failure
Heart failure patients exercise, improve quality of life
Half an hour of walking can lower risks for heart failure patients
DCRI researchers identify protein signature that may predict who responds to hepatitis C treatment
Several methods are effective for treating teens with anxiety disorder
Duke named one of three AHA Pharmaceutical Roundtable Outcomes Research Centers
DCRI research finds that vaccinating families of newborns help protect infants from the flu
DCRI's John Sundy leads research on possible new treatment for patients with gout
On a more level playing field, hospitals’ pay-for-performance rankings shift
Study finds link between depression and higher risk of death for patients on chronic dialysis
Testing changes in electrical activity in the heart immediately following PCI can better predict necessary care
Researchers identify genes that might indicate the extent of coronary artery disease in patients
VIGOUR hopes for more researchers in developing countries
Nursing intervention helps relieve depression in patients with heart failure
Study finds new anti-blood clot drug increases bleeding but lowers heart attack risk
Bacteria in the blood likely signals device infection in patients with pacemakers, defibrillators
Patients with heart failure face greater risk of death following ICD shocks
Defibrillators reduce risk of death without diminishing quality of life
Post-market monitoring crucial to detecting adverse side effects of drugs used in children
Low levels of “good” cholesterol may be a prognostic indicator and target for intervention
Some financial relationships don't impact patient enrollment in trials
Hospitals made improvements during CRUSADE but there is room for further improvements
Novel strategies needed to decrease mortality risk in elderly women with heart disease
DCRI researchers find safer way to insert coronary stents is rarely used
DCRI researchers find younger, white patients more likely to undergo cardiac resynchronization
DCRI researchers weigh benefits of smaller versus larger drug-safety databases
DCRI researchers propose framework for studying CV imaging technologies
Atrial fibrillation is associated with greater risk of death for acute coronary patients
Experts examine key issues related to post-market evaluation of medical devices
Smokers with coronary syndrome are younger, but don't have higher mortality rates
Community hospitals don't transfer many patients who need cardiac catheterization
ED-based research needed to improve quality and reduce disparities in emergency care
New study finds women with heart disease, diabetes have worse stroke outcomes
New guidelines recommend cholesterol screening for overweight kids
Informed consent essential to fostering trust in medical research
Trial indicates new anticoagulant and antidote could be safe, fast option for patients
Screening older patients for HIV can be a cost-effective health tool
Heart failure patients overestimate their life span
Despite treatment delays, off-hour heart attack patients don't have increased risk of death
Despite treatment delays, off-hour heart attack patients don't have increased risk of death
Research about coronary stents does not always disclose authors' financial stakes
New drug-eluting stents not any safer than traditional stents, according to a new study
JAMA editorial: Eric Peterson and Tracy Wang on preventive cardiology
Trial participants not overly concerned by researchers' financial interests in trials
Late-breaking clinical trial at ACC: Groundbreaking results from ACCOMPLISH
ACC presentation: Making progress including women in clinical trials
Late-breaking clinical trial at ACC: MEND-CABG II trial results
Late-breaking clinical trial at ACC: Home Automated External Defibrillator Trial results
ACC presentation: Warning signs of sudden cardiac death after heart attack
Late-breaking clinical trial at ACC: Angioplasty at medical centers without on-site cardiac surgery
Lack of NIH funding increases is straining younger researchers
Pessimistic heart patients have higher risk of death
Coronary bypass surgery effective but high-risk procedure for cardiogenic shock patients
More elderly Americans are living with heart failure
Acute hypertension patients don't receive enough follow-up
Drug used in cardiac surgery increases mortality rate, DCRI researchers confirm
Inaugural Class of Global Health Residency Program Announced
New drug could minimize damage from heart attack treatment
Blood clot treatment puts patients at greater risk of decreased level of platelets
DCRI researchers complete first study on anti-clotting drugs for children
Lower doses of aspirin are safer and as effective
Global blood transfusion patterns raise questions
   
Site Map Contact Us Links Help Terms of Use © 2003-2009 Duke Clinical Research Institute.